This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of oral cavity
CD2_INSITU_ORALCAVITY
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
519030 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
35 |
4. Check minimum number of eventsNone |
35 |
5. Include endpoints |
74 |
6. Filter based on genotype QC (FinnGen only) |
74 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ labii (oris)
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of oral cavity
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of oral cavity
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 74 | 26 | 48 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 68.07 | 70.39 | 66.81 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 65
- Matched controls
- 648
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
90.1
25.5
27
5
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
+∞
15.2
14
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
34.7
14.3
18
7
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
95.6
14.2
15
*
K13.29
ICD-10 Finland
Indefinite leukoplakia
72.3
11.0
12
*
D00.00
ICD-10 Finland
Cancer in situ on the lip red border
+∞
10.7
10
*
8070/2-C00.1
ICD-O-3
Squamous cell carcinoma in situ, NOS, of external lower lip
+∞
9.6
9
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
9.6
9
*
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
7.4
7
*
K13.78
ICD-10 Finland
Other change in the oral mucosa
16.2
7.2
11
8
EP1AE
NOMESCO Finland
Neck ultrasound examination
11.3
7.2
13
14
D00.05
ICD-10 Finland
In situ cancer of the pharyngeal part of the tongue
+∞
6.3
6
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
9.5
6.2
12
15
WX110
NOMESCO Finland
Local anesthesy
4.2
6.0
52
317
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
22
57
5.07
8.43
1.6
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
42
215
3.20
5.71
3.5
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
16
48
3.98
4.94
10.7
8.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
43
253
2.67
4.11
5.3
3.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
25
4.47
3.84
11.8
7.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
97
2.80
3.64
2.4
2.2
e6/l
0.3
1.2
1.42
13
56
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
21
91
2.83
3.58
2.5
2.5
e6/l
1.4
2.0
0.22
12
51
(4035726)
15
54
3.23
3.50
1.7
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
28
146
2.48
3.29
7.0
3.2
%
85.1
84.8
0.02
28
140
(3044640) Blood type and Crossmatch panel - Blood
33
189
2.35
3.13
3.9
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
35
3.52
3.07
1.8
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
26
140
2.32
2.79
4.0
2.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
42
277
2.19
2.75
9.8
6.1
mmol/l
1.2
1.2
0.70
37
229
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
35
215
2.19
2.73
3.1
2.9
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
11
38
3.23
2.71
13.5
6.9
%
0.7
0.7
0.03
11
38
(3030467) Casts [#/volume] in Urine by Automated count
30
174
2.22
2.69
3.1
2.8
e6/l
1.4
0.5
0.77
19
126
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
11
5.82
2.59
1.2
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
7
7.55
2.59
1.4
2.7
%
9.5
12.5
—
5
7
(36304419) Bacteria [Presence] in Urine
29
169
2.18
2.55
3.1
2.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
31
187
2.13
2.49
3.4
3.0
e6/l
84.9
379.3
0.40
20
142
(3000494) Fungus identified in Specimen by Culture
15
66
2.60
2.44
2.1
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
8
6.60
2.41
6.0
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
33
210
2.03
2.26
3.7
3.6
e6/l
75.9
133.3
0.36
21
154
(3019832) Treponema pallidum Ab [Presence] in Serum
7
20
3.75
2.11
1.4
2.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
10
38
2.89
2.11
14.7
6.3
%
0.9
1.4
—
10
38
(3019230) Fractional oxyhemoglobin in Venous blood
5
10
5.27
2.10
1.8
2.8
%
50.6
68.0
—
5
10
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
8
27
3.19
2.00
2.0
2.5
%
0.6
0.7
—
8
27
(1761868) Lipid panel - Serum or Plasma
9
190
0.40
2.00
4.1
2.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
12
53
2.51
1.92
1.3
2.5
%
1.8
1.5
0.43
12
43
(3019309) Folate [Moles/volume] in Red Blood Cells
21
120
2.05
1.88
1.3
1.7
nmol/l
1452.9
1291.7
0.25
14
88
(3004119) Hemoglobin [Mass/volume] in Venous blood
9
35
2.78
1.87
1.9
3.6
g/l
132.0
130.1
—
9
35
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
29
2.97
1.85
2.0
2.5
%
1.7
1.6
—
8
29
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
14
68
2.31
1.84
2.4
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
14
69
2.27
1.78
2.0
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
21
126
1.93
1.63
1.6
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
20
3.17
1.61
1.5
4.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
37
267
1.77
1.59
6.9
9.3
inr
1.6
1.3
—
8
80
(3012544) pH of Venous blood
12
58
2.28
1.59
2.5
4.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
65
566
2.22
1.56
25.5
15.4
mg/l
40.1
24.3
1.76
55
468
(42870588) Differential panel, method unspecified - Blood
29
196
1.79
1.55
5.2
5.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
17
99
1.93
1.42
2.8
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
17
3.08
1.38
1.8
2.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
30
211
1.71
1.37
2.0
2.2
nmol/l
82.5
74.0
0.70
25
177
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
40
307
1.66
1.30
3.3
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
33
243
1.65
1.25
1.9
2.0
pmol/l
98.1
93.0
0.25
14
121
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
72
1.98
1.24
1.5
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
65
584
1.93
1.15
18.2
15.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
59
2.02
1.14
1.3
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
36
276
1.59
1.13
6.0
5.1
e9/l
0.6
0.6
1.00
30
236
(3012516) Albumin [Mass/volume] in Urine
24
167
1.65
1.11
3.7
3.2
mg/l
44.6
461.4
0.57
18
108
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
45
2.14
1.10
9.7
4.4
mmol/l
24.0
24.6
—
9
45
(3026493) Urate [Moles/volume] in Serum or Plasma
10
171
0.52
1.09
2.8
2.5
umol/l
370.0
10825.3
—
10
145
(3006315) Basophils [#/volume] in Blood
36
278
1.57
1.09
6.0
5.2
e9/l
0.0
0.0
0.41
30
240
(3019198) Lymphocytes [#/volume] in Blood
36
281
1.55
1.02
6.1
5.3
e9/l
1.6
1.9
1.07
31
246
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
54
1.98
1.02
1.4
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
36
2.04
1.00
1.3
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
0
30
0.00
1.00
0.0
1.2
—
255.1
—
0
24
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
51
1.87
0.99
2.1
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
24
172
1.59
0.98
3.5
3.0
mmol/l
5.1
7.5
4.72
19
143
(3023368) Bacteria identified in Blood by Culture
25
181
1.58
0.98
10.0
4.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
56
486
1.63
0.97
31.9
16.8
%
35.4
40.1
1.61
38
322
(3041096) Erythrocytes [Presence] in Urine by Automated
10
165
0.54
0.96
3.2
3.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
16
230
0.61
0.92
3.1
3.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
29
2.16
0.91
1.2
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
43
1.96
0.91
1.4
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
32
251
1.48
0.86
7.5
10.4
e9/l
0.0
0.0
0.62
25
209
(3020564) Creatinine [Moles/volume] in Serum or Plasma
65
595
1.76
0.80
29.8
18.4
umol/l
86.4
84.4
0.12
65
595
(3002385) Erythrocyte distribution width [Ratio]
51
443
1.49
0.79
32.5
19.7
%
13.9
13.9
0.04
51
432
(40760892) CBC W Ordered Manual Differential panel - Blood
7
118
0.55
0.76
5.1
5.6
—
—
—
0
0
(3013512) EKG study
14
198
0.64
0.73
4.8
4.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
24
183
1.46
0.72
4.2
3.8
mg/mmol
7.7
12.7
0.51
16
114
(3026008) Bacteria identified in Urine by Culture
23
174
1.47
0.72
4.0
2.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
47
406
1.43
0.72
3.6
3.6
pmol/l
15.0
14.9
0.14
42
361
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
42
1.73
0.70
1.6
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
42
1.73
0.70
6.0
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
27
1.91
0.70
1.2
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
43
1.69
0.69
2.1
2.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
29
1.78
0.65
1.4
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
59
537
1.49
0.63
7.2
6.1
mmol/mol
41.8
40.7
0.33
53
496
(40758558) Short blood count panel - Blood
19
142
1.45
0.63
7.7
6.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
8
52
1.60
0.62
3.9
2.3
u/l
25.4
30.3
—
8
40
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
20
0.00
0.61
0.0
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
21
0.00
0.61
0.0
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
0
21
0.00
0.61
0.0
1.8
—
38.1
—
0
15
(1002224) Polysomnography panel
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
9
63
1.49
0.55
2.2
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
37
319
1.32
0.51
12.2
9.5
e9/l
4.3
4.3
0.03
32
278
(3044889) 12 lead EKG panel
45
399
1.33
0.51
4.1
4.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
44
389
1.32
0.51
4.5
4.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
7
47
1.54
0.49
2.6
2.0
nmol/l
371.6
327.1
—
7
41
(4010399)
7
49
1.47
0.47
1.6
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
0
16
0.00
0.41
0.0
3.2
—
15.3
—
0
6
(3001019) Free T4 and TSH panel - Serum or Plasma
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
16
129
1.31
0.34
2.3
3.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
75
1.39
0.32
6.2
9.2
—
—
—
0
0
(3019225) pH of Specimen
7
56
1.28
0.30
12.0
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
62
1.33
0.29
1.3
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
52
551
0.81
0.28
4.5
4.1
mmol/l
1.6
1.3
0.84
45
490
(3042936) Bacteria identified in Isolate by Culture
12
95
1.31
0.28
4.0
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
56
531
1.22
0.25
25.1
15.1
ml/min/173m2
77.0
76.0
0.12
47
439
(3000492) Spirometry study
5
40
1.27
0.23
1.2
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
5
40
1.27
0.23
4.0
2.6
—
7.4
—
0
6
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
11
0.00
0.21
0.0
2.7
—
6.3
—
0
11
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
4.0
—
86.5
—
0
10
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
10
0.00
0.21
0.0
1.3
—
143.0
—
0
10
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
16.6
—
0
12
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
12
0.00
0.21
0.0
4.1
—
57.7
—
0
12
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
54
564
0.84
0.20
4.8
4.6
mmol/l
1.5
1.4
0.31
46
504
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
62
1.14
0.18
2.4
4.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
6
75
0.78
0.16
1.3
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
261
1.12
0.12
3.2
4.1
ng/l
28.0
52.9
1.10
19
206
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
55
566
0.89
0.11
4.6
4.6
mmol/l
4.3
4.5
0.73
48
512
(3015736) pH of Urine
20
213
0.92
0.07
2.9
3.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
57
581
0.92
0.05
5.4
5.2
mmol/l
2.3
2.6
2.31
51
517
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
23
228
1.01
0.00
4.2
4.2
%
13.1
21.3
—
7
115
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6
67
0.89
0.00
1.0
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
5
0.00
0.00
0.0
1.2
—
32.2
—
0
5
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
289.8
—
0
6
(3051611) Lipemic interference index of Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.3
—
14.3
—
0
6
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.7
—
0
6
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
51
0.98
0.00
1.8
2.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
341.8
—
0
6
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(4024509)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
11.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.5
—
0.8
—
0
8
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
7.3
—
0
6
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
6.9
—
0
8
(3045424) Erythrocytes [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_ORALCAVITY – Carcinoma in situ of oral cavity
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).